A cross-sectoral study to individually optimize therapy in heart failure- "AMPEL" trial

L. Brunelli, Günter Schreier, D. Hayn, K. Kreiner, A. Lauschensky, F. Wiesmüller, M. Baumgartner, B. Pfeifer, S. Neururer, A. Bauer, G. Poelzl

Publikation: Posterpräsentation ohne Beitrag in TagungsbandPosterpräsentation ohne Eintrag in TagungsbandBegutachtung

Abstract

 Introduction:
Guideline-directed medical treatment (GDMT) beyond the hospitalization phase is crucial for a stable
course of the disease and better survival. Nevertheless, several studies show a clear need for optimization regarding both initiation and dosing of GDMT in the context of daily clinical practice. Several eforts have been made to improve adherence to the use of GDMT, but no signifcant results have been shown to date in terms of treatment optimization and clinical outcome.
The Assisted Therapy Optimizing Module has been designed to actively assist physicians in adhering to and improving guideline-based medical therapy in the context of a multidisciplinary heart failure management program.

Methods:
The Assisted Therapy Optimizing module is a graphical visualization of the diferent drug classes and the percentage of each prescribed target dose according to the current guidelines for the treatment of chronic heart failure patients with reduced ejection fraction (HFrEF) published by the European Society of Cardiology. If a drug class or dose increase is contraindicated, the physicians can choose from a predefned selection of absolute or relative contraindications and document this in the system. To achieve a high level of GDMT consistency, the selection options are limited exclusively to the contraindications listed in the guidelines. Te time-limited
OriginalspracheEnglisch
SeitenS388-S388
Seitenumfang1
DOIs
PublikationsstatusVeröffentlicht - Mai 2023
VeranstaltungÖsterreichische Kardiologische Gesellschaft Jahrestagung 2023: „Wissenschaft und Praxis im Dialog“ - Salzburg-Congress, Salzburg, Österreich
Dauer: 31 Mai 20233 Juni 2023
https://atcardio.at/oekg-jahrestagung#okg-jahrestagung-2023

Konferenz

KonferenzÖsterreichische Kardiologische Gesellschaft Jahrestagung 2023
KurztitelÖKG Jahrestagung 2023
Land/GebietÖsterreich
StadtSalzburg
Zeitraum31/05/233/06/23
Internetadresse

Research Field

  • Exploration of Digital Health

Web of Science subject categories (JCR Impact Factors)

  • Medicine, General & Internal

Fingerprint

Untersuchen Sie die Forschungsthemen von „A cross-sectoral study to individually optimize therapy in heart failure- "AMPEL" trial“. Zusammen bilden sie einen einzigartigen Fingerprint.

Diese Publikation zitieren